Category

Biotechs

Biotechnology

The NFL's Biggest Problem Could Be Pharmaceutical Cannabis' Biggest Breakthrough

America loves its football, and football fans love a big hit. For years, the National Football League prepared promotional videos showing the biggest hits from each week – videos its network associates eagerly aired to gin up even more interest in the coming week's games.

But those "big hits" were the genesis of a shameful legacy in the NFL: Concussions – and a terrifying disease called chronic traumatic encephalopathy.

CTE is a degenerative brain disease brought on by too many big concussions received over the years. CTE causes memory problems, cognitive difficulties, and, eventually, even dementia.

To be fair, CTE is also a problem among combat military personnel, hockey players, soccer players, pro fighters, and others, but the CTE story broke in the NFL.

There is no cure. In fact, it can't even be diagnosed in a living brain; a post-mortem examination is needed to even find CTE.

And it has caused plenty of deaths. Several NFL players with CTE have committed suicide; a few have committed murder. Dozens of others have surrendered what should have been a happy retirement to a lifetime of pain and mental illness.

And the NFL almost surely knew. How could it not?

The league even paid a settlement in excess of $1 billion to avoid a trial in which evidence scheduled to be presented would have suggested just how much they knew… and when they knew it.

To its credit, the modern NFL is cleaning up its act. It has changed the rules to make concussions less frequent. It's changed other rules to get players with head injuries out of games until they can pass concession-testing protocol.

But concussions will still occur, and some players will get enough concussions to get CTE.

But what if there were a cure? Even better, what if CTE could be prevented?

One company I know of is researching those very same questions. This firm is being advised by a retired NFL player with degrees from Harvard and Dartmouth.

The team aims to discover whether CTE can be cured or even prevented with cannabis.

The research is exciting – and promising. If this firm succeeds, it will do a tremendous amount of good.

And shareholders, of course, could clean up, too...

stocks

The 3 Biotech Stocks You Need in Your Portfolio

The numbers are staggering. Over the next six years, the biotech market is expected to add an additional $593 billion in value – a 419% increase over the size of today's biotech market.

Growth like this is why Wall Street is rushing hand over foot to buy the most lucrative biotech stocks available. With thousands of biotech stocks on the market, identifying the best biotech stocks to buy is incredibly difficult.

However, using the Money Morning Stock VQScore™ system, we've identified 3 biotech stocks that are on track to deliver triple-digit returns.

Biotechnology

This Tiny $7 Stock Is Sitting on a Revolutionary Biotech Breakthrough

A tiny $7 company has developed a breakthrough solution that could protect 50 million American men from the ravages of prostate cancer…

Not only could it help protect you, me, and 50 million American men from the perils of prostate cancer…

But it could also deliver a massive financial windfall, the likes of which most folks only dream about...

Biotechnology

How to Find Tiny Stocks Packing Quadruple-Digit Profit Potential

Micro-cap and penny biotech stocks (those with a market cap at less than $300 million) have a reputation for being extremely speculative, volatile, and unpredictable.

But they can also deliver returns beyond your wildest expectations.

In fact, some of these companies have become legendary for minting millionaires, as they rocketed from bargain basement to stellar valuation. Others, of course, crashed and burned along the way.

In this investment niche, little is certain, but a little legwork can give you an edge when picking the winners from the also-rans.

In a moment, I'm going to show you two things I always look for when I'm researching these special stocks for my Biotech Insider Alert subscribers.

But first, I'll tell you what not to look for. That's going to save you a lot of time...

stocks

The 3 Best Biotech Stocks to Buy in June 2018

By 2025, the biotech industry will be worth will be $727 billion – a 120% increase over its total value in 2015.

To help you take advantage of the tremendous gains in biotech stocks, we're bringing you the three best biotech stocks to buy this month.

You see, Wall Street has put some of the best biotech stocks "on sale" due to fears over development delays, Washington's pushback against high drug prices, and a lack of consumer demand.